| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8698 | 
      | Human Intestinal Absorption | HIA+ | 0.9823 | 
      | Caco-2 Permeability | Caco2+ | 0.9221 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5133 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.6117 | 
                                                     | Non-inhibitor | 0.6352 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8542 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5314 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8061 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8956 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5861 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9692 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.5811 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8248 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.5383 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.5703 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5765 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9394 | 
                                                                    | Non-inhibitor | 0.9522 | 
      | AMES Toxicity | AMES toxic | 0.6196 | 
      | Carcinogens | Non-carcinogens | 0.9244 | 
      | Fish Toxicity | High FHMT | 0.8503 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9719 | 
      | Honey Bee Toxicity | High HBT | 0.8686 | 
      | Biodegradation | Not ready biodegradable | 0.5285 | 
      | Acute Oral Toxicity | III | 0.5457 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5640 |